GATA-3 is expressed in association with estrogen receptor in breast cancer

International Journal of Cancer

Volumn 84, Issue 2, 1999, Pages 122-128

  Hoch, Renee V ^a   Thompson, Devon A ^a   Baker, Robin J ^b   Weigel, Ronald J ^a,c  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 3; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER HORMONE THERAPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA LIBRARY; HORMONE RESPONSE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; STRAIN DIFFERENCE;

BLOTTING, NORTHERN; BREAST NEOPLASMS; DNA-BINDING PROTEINS; ESTRADIOL; FEMALE; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0032971250     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990420)84:2<122::AID-IJC5>3.0.CO;2-S     Document Type: Article

References (33)

1. BLOBEL, G.A. and ORKIN, S.H., Estrogen-induced apoptosis by inhibition of the erythroid transcription factor GATA-1. Mol. cell. Biol., 16, 1687-1694 (1996).
2. BLOBEL, G.A., SIEFF, C.A. and ORKIN, S.H., Ligand-dependent repression of the erythroid transcription factor GATA-1 by the estrogen receptor. Mol. cell. Biol., 15, 3147-3153 (1995).
3. CARMECI, C., THOMPSON, D.A., RING, H.Z., FRANCKE, U. and WEIGEL, R.J., Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics, 45, 607-617 (1997).
4. CASTLES, C.G., FUQUA, S.A.W., KLOTZ, D.M. and HILL, S.M., Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line. Cancer Res., 53, 5934-5939 (1993).
5. DECONINCK, E.C., MCPHERSON, L.A. and WEIGEL, R.J., Transcriptional regulation of estrogen receptor in breast carcinomas. Mol. cell. Biol., 15, 2191-2196 (1995).
6. DIGNAM, J.D., LEBOVITZ, R.M. and ROEDER, R.G., Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res., 11, 1475-1489 (1983).
7. Ho, I.-C., VORHEES, P., MARIN, N., OAKLEY, B.K., TSAI, S.-F., ORKIN, S.H. and LEIDEN, J.M., Human GATA-3: a lineage-restricted transcription factor that regulates the expression of the T cell receptor a gene. EMBO J., 10, 1187-1192 (1991).
8. INCE, B.A., ZHUANG, Y., WRENN, C.K., SHAPIRO, D.J. and KATZENELLENBOGEN, B.S., Powerful dominant negative mutants of the human estrogen receptor. J. biol. Chem., 268, 14026-14032 (1993).
9. JIANG, S.-Y. and JORDAN, V.C., Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. J. natl. Cancer Inst., 84, 580-591 (1992).
10. JORDAN, V.C., WOLF, M.F., MIRECKI, D.M., WHITFORD, D.A. and WELSHONS, W.V., Hormone receptor assays: clinical usefulness in the management of carcinoma of the breast. CRC Crit. Rev. Clin. Lab. Sci., 26, 97-152 (1988).
11. JOULIN, V., BORIES, D., ELEOUET, J.-F., LABASTIE, S.C., MATTEI, M.-G. and ROMEO, P.-H., A T-cell specific TCR δ DNA binding protein is a member of the human GATA family. EMBO J., 10, 1809-1816 (1991).
12. KATO, S., ENDOH, H., MASUHIRO, Y., KITAMOTO, T., UCHIYAMA, S., SASAKI, H., MASUSHIGE, S., GOTOH, Y., NISHIDA, E., KAWASHIMA, H., METZGER, D. and CHAMBON, P., Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science, 270, 1491-1494 (1995).
13. KNIGHT, III, W.A., LIVINGSTON, R.B., GREGORY, E.J. and MCGUIRE, W.L., Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res., 37, 4669-4671 (1977).
14. KNIGHT, III, W.A., OSBORNE, C.K., YOCHMOWITZ, M.G. and MCGUIRE, W.L., Steroid hormone receptors in the management of human breast cancer. Ann. clin. Res., 12, 202-207 (1980).
15. Ko, L.J. and ENGEL, J.D., DNA-binding specificities of the GATA transcription factor family. Mol. cell. Biol., 13, 4011-4022 (1993).
16. KUANG, W.W., THOMPSON, D.A., HOCH, R.V. and WEIGEL, R.J., Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line. Nucleic Acids Res., 26, 1116-1123 (1998).
17. LAVERRIERE, A.C., MACNEILL, C., MUELLER. C., POELMANN, R.E., BURCH, J.B.E. and EVANS, T., GATA-4/5/6, a subfamily of three transcription factors transcribed in developing heart and gut. J biol. Chem., 269, 23177-23184 (1994).
18. LONGACRE, T.A., SMOLLER, B.R. and ROUSE, R.V., Atypical fibroxanthoma: multiple immunohistologic profiles. Amer. J. surg. Pathol., 17, 1199-1209 (1993).
19. MASIAKOWSKI, P., BREATHNACH, R., BLOCH, J., GANNON, R., KRUST, A. and CHAMBON, P., Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res., 10, 7895-7903 (1982).
20. MCPHERSON, L.A., BAICHWAL, V.R. and WEIGEL, R.J., Identification of ERF-1 as a member of the AP2 transcription factor family. Proc. nat. Acad. Sci. (Wash.), 94, 4342-4347 (1997).
21. ORKIN, S.H., GATA-binding transcription factors in hematopoietic cells. Blood. 80, 575-581 (1992).
22. PAECH, K., WEBB, P., KUIPER, G.G.J.M., NILSSON, S., GUSTAFSSON, J.-Å., KUSHNER, P.J. and SCANLAN, T.S., Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science, 277, 1508-1510 (1997).
23. PFEFFER, U., FECAROTTA, E., ARENA, G., FORLANI, A. and VIDALI, G., Alternative splicing of the estrogen receptor primary transcript normally occurs in estrogen receptor positive tissues and cell lines. J. Steroid Biochem. mol. Biol., 56, 99-105 (1996).
24. PFEFFER, U., FECAROTTA, E., CASTAGNETTA, L. and VIDALI, G., Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-responsive human breast cancer cell lines. Cancer Res., 53, 741-743 (1993).
25. PHILIPS, A., CHALBOS, D. and ROCHEFORT, H., Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis. J. Biol. Chem.. 268, 14103-14108 (1993).
26. SANGER, F. and COULSON, A.R., A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase. J. mol. Biol., 94, 441-448 (1975).
27. SAVOURET, J.-F., RAUCH, M., REDEUILH, G., SAR, S., CHAUCHEREAU, A., WOODRUFF, K., PARKER, M.G. and MILOROM, E., Interplay between estrogens, progestins, retinoic acid and AP-1 on a single regulatory site in the progesterone receptor gene. J. biol. Chem., 269, 28955-28962 (1994).
28. SLUYSER, M., Role of estrogen receptor variants in the development of hormone resistance in breast cancer. Clin. Biochem., 25, 407-414 (1992).
29. TANG, Z., TREILLEUX, I. and BROWN, M., A transcriptional enhancer required for the differential expression of the human estrogen receptor in breast cancers. Mol. cell. Biol., 17, 1274-1280 (1997).
30. THOMPSON, D.A., MCPHERSON, L.A., CARMECI, C., DECONINCK, E.C. and WEIGEL, R.J., Identification of two estrogen receptor transcripts with novel 5′ exons isolated from a MCF7 cDNA library. J. Steroid Biochem. mol. Biol., 62, 143-153 (1997).
31. THOMPSON, D.A. and WEIGEL, R.J., Characterization of a gene that is inversely correlated with estrogen receptor expression (ICERE-I) in breast carcinomas. Europ. J. Biochem., 252, 169-177 (1998).
32. TSAI, S.-F., MARTIN, D.I.K., ZON, L.I., D'ANDREA, A.D., WONG, G.G. and ORKIN, S.H., Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells. Nature (Lond.), 339, 446-451 (1989).
33. VAN DE RIJN, M., HENDRICKSON, M.R. and ROUSE, R.V., CD34 expression by gastrointestinal tract stromal tumors. Hum. Pathol., 25, 766-771 (1994).